cytostatic

简明释义

英[ˌsaɪtəʊˈstætɪk]美[ˌsaɪtəˈstætɪk]

adj. 抑制细胞生长的

n. 细胞抑制剂

英英释义

单词用法

同义词

反义词

例句

1.Objective response is a weak surrogate of activity in phase II trials, since in most cases, the predominant effect of these compounds is basically cytostatic.

客观反映在II期试验中只是一个活性的微弱代表，因为在大多病例中，这些组合的主要作用是以细胞抑制为基础的。

2.Objective response is a weak surrogate of activity in phase II trials, since in most cases, the predominant effect of these compounds is basically cytostatic.

客观反映在II期试验中只是一个活性的微弱代表，因为在大多病例中，这些组合的主要作用是以细胞抑制为基础的。

3.The availability of new cytostatic agents and other drugs may improve the resectability of liver metastases and prolong the survival in advanced disease.

新的抗癌药物和其它药物的推出可增加肝转移癌的切除机会，并延长晚期患者的生存期。

4.Streptokinase and urokinase are important in thrombolytics, and asparaginase is used as a cytostatic agent in the treatment of leukemia.

链激酶和尿激酶溶栓是重要的，是天冬酰胺酶在治疗白血病细胞生长剂。

5.The oncologist prescribed a cytostatic drug to slow down the growth of the tumor.

肿瘤科医生开了一种细胞静止药物，以减缓肿瘤的生长。

6.Patients undergoing chemotherapy often receive cytostatic treatments to combat cancer.

接受化疗的患者通常会接受细胞静止治疗以对抗癌症。

7.Research shows that certain cytostatic agents can also affect healthy cells.

研究表明，某些细胞静止剂也会影响健康细胞。

8.The effectiveness of the cytostatic therapy was monitored through regular scans.

通过定期扫描监测细胞静止疗法的有效性。

9.New combinations of cytostatic drugs are being tested in clinical trials.

新的细胞静止药物组合正在临床试验中测试。

作文

In the field of medicine, particularly in oncology, the term cytostatic refers to substances that inhibit cell growth and division. These agents are crucial in the treatment of cancer, as they target rapidly dividing cells, which is a hallmark of malignant tumors. The primary goal of cytostatic therapies is to halt the proliferation of cancer cells, thereby reducing tumor size and preventing metastasis. Understanding how cytostatic agents work can provide insights into their significance in cancer treatment and the ongoing research aimed at improving their efficacy. Cancers are characterized by uncontrolled cell growth, and this is where cytostatic drugs come into play. By interfering with the cell cycle, these drugs can induce cell death or prevent cells from dividing. There are various classes of cytostatic agents, including alkylating agents, antimetabolites, and plant alkaloids, each working through different mechanisms. For example, alkylating agents damage DNA, preventing cancer cells from replicating successfully. Antimetabolites mimic the building blocks of DNA and RNA, thus disrupting the synthesis of genetic material essential for cell division. Plant alkaloids, derived from plants, can inhibit the mitotic spindle formation, leading to cell cycle arrest. While cytostatic therapies have proven effective in many cases, they are not without side effects. Because these drugs also affect normal cells that divide rapidly, such as those in the bone marrow, gastrointestinal tract, and hair follicles, patients often experience adverse effects like nausea, hair loss, and increased susceptibility to infections. This highlights the importance of ongoing research to develop more targeted therapies that can minimize harm to healthy cells while maximizing the impact on cancerous ones. Recent advancements in cancer treatment have led to the development of targeted therapies and immunotherapies, which complement traditional cytostatic treatments. Targeted therapies focus on specific molecular targets associated with cancer, allowing for a more personalized approach to treatment. Immunotherapy, on the other hand, harnesses the body’s immune system to recognize and attack cancer cells. These innovative strategies aim to improve patient outcomes and reduce the reliance on traditional cytostatic agents alone. In conclusion, the role of cytostatic agents in cancer treatment cannot be overstated. They form the backbone of many chemotherapy regimens and have significantly improved survival rates for various types of cancer. As research continues to evolve, the hope is that future therapies will enhance the effectiveness of cytostatic treatments while minimizing side effects, ultimately leading to better quality of life for patients battling cancer. Understanding the mechanisms and implications of cytostatic therapies is essential for both medical professionals and patients alike, as it empowers them to make informed decisions regarding cancer treatment options.

在医学领域，特别是在肿瘤学中，术语cytostatic指的是抑制细胞生长和分裂的物质。这些药物在癌症治疗中至关重要，因为它们针对快速分裂的细胞，这是恶性肿瘤的特征。cytostatic治疗的主要目标是阻止癌细胞的增殖，从而减小肿瘤大小并防止转移。理解cytostatic药物的作用机制可以提供其在癌症治疗中的重要性的见解，以及旨在提高其疗效的持续研究。 癌症的特点是细胞的失控生长，而这正是cytostatic药物发挥作用的地方。通过干扰细胞周期，这些药物可以诱导细胞死亡或阻止细胞分裂。cytostatic药物有多种分类，包括烷化剂、抗代谢物和植物生物碱，每种药物通过不同的机制发挥作用。例如，烷化剂会损伤DNA，阻止癌细胞成功复制。抗代谢物模仿DNA和RNA的构建块，从而破坏细胞分裂所必需的遗传物质的合成。植物生物碱则源自植物，可以抑制有丝分裂纺锤体的形成，导致细胞周期停滞。 尽管cytostatic治疗在许多情况下证明有效，但它们并非没有副作用。由于这些药物也会影响正常的快速分裂细胞，例如骨髓、胃肠道和毛囊中的细胞，患者常常会经历恶心、脱发和感染易感性增加等不良反应。这突显了持续研究的重要性，以开发更具针对性的疗法，最大限度地减少对健康细胞的伤害，同时最大化对癌细胞的影响。 近年来，癌症治疗的进展导致了靶向疗法和免疫疗法的发展，这些疗法补充了传统的cytostatic治疗。靶向疗法专注于与癌症相关的特定分子靶点，从而允许更个性化的治疗方法。另一方面，免疫疗法利用身体的免疫系统来识别和攻击癌细胞。这些创新策略旨在改善患者的预后，并减少对传统cytostatic药物的依赖。 总之，cytostatic药物在癌症治疗中的作用不容小觑。它们构成了许多化疗方案的基础，并显著提高了各种类型癌症的生存率。随着研究的不断发展，希望未来的疗法能够增强cytostatic治疗的有效性，同时最小化副作用，最终为与癌症作斗争的患者带来更好的生活质量。理解cytostatic治疗的机制和影响对于医疗专业人员和患者来说都是至关重要的，因为这使他们能够就癌症治疗选择做出明智的决定。